The Shifting Landscape for Specialty Pharmacy Patients

By Davy James, Managing Editor

David Lassen, chief clinical officer at Prime Therapeutics, discusses changes in store for the field of specialty pharmacy in the coming years.

David Lassen, chief clinical officer at Prime Therapeutics, discusses changes in store for the field of specialty pharmacy in the coming years.

Related Videos
View All
Related Content

COVID-19 Public Health Measures May Have Lowered Cases of Respiratory Syncytial Virus

January 26th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Experts Review Treatments, Directions in Basal Cell Carcinoma

January 26th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Investigational RSV Vaccine Demonstrates 83.7% Efficacy in Clinical Trial

January 26th 2023

Pembrolizumab Plus Chemotherapy Significantly Improves Overall Survival in First-Line Advanced, Unresectable Biliary Tract Cancer

January 26th 2023

COVID-19 Public Health Measures May Have Lowered Cases of Respiratory Syncytial Virus

January 26th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Experts Review Treatments, Directions in Basal Cell Carcinoma

January 26th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Investigational RSV Vaccine Demonstrates 83.7% Efficacy in Clinical Trial

January 26th 2023

Pembrolizumab Plus Chemotherapy Significantly Improves Overall Survival in First-Line Advanced, Unresectable Biliary Tract Cancer

January 26th 2023

COVID-19 Public Health Measures May Have Lowered Cases of Respiratory Syncytial Virus

January 26th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Experts Review Treatments, Directions in Basal Cell Carcinoma

January 26th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Investigational RSV Vaccine Demonstrates 83.7% Efficacy in Clinical Trial

January 26th 2023

Pembrolizumab Plus Chemotherapy Significantly Improves Overall Survival in First-Line Advanced, Unresectable Biliary Tract Cancer

January 26th 2023
About Us
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.